Every drug testing program eventually runs into the same question from an employee who tests positive for marijuana: “I don’t smoke, but I was around people who did. Could that be why?” It’s a reasonable thing to wonder, and it’s a question HR and compliance teams should be able to answer with more than a guess.
The short version is that passive exposure to cannabis smoke almost never produces a positive result under real-world conditions and standard testing cutoffs. But “almost never” is not the same as “never,” and the exceptions matter enough that a program should understand them rather than wave the question away.
Why This Comes Up So Often
Secondhand smoke claims are one of the most common explanations employees offer for an unexpected positive result, right alongside CBD products and poppy seed myths. Part of the reason is that it sounds plausible. Cannabis smoke is visible, it has a strong odor, and most people have had the experience of smelling it from a distance. It’s natural to assume that if you can smell it, you might be absorbing enough of it to test positive.
The research tells a more specific story than that assumption suggests.
What the Research Actually Shows
The most detailed study on this question was conducted by researchers including Edward Cone and Ron Flegel at a controlled laboratory setting, where nonsmoking volunteers sat in an unventilated room with several people actively smoking cannabis cigarettes over the course of an hour. Researchers then measured THC concentrations in the nonsmokers’ blood and oral fluid, and tracked how those levels compared to typical workplace testing cutoffs. The study, Nonsmoker Exposure to Secondhand Cannabis Smoke III: Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects, is one of the few that actually measured passive exposure under conditions designed to produce the highest realistic dose, an unventilated room with multiple active smokers at close range.
Under those extreme conditions, some nonsmoking participants did show measurable THC in oral fluid shortly after exposure. But the levels were low, cleared quickly, usually within a few hours, and in most cases fell below the cutoff concentrations used in standard workplace oral fluid testing. The researchers’ broader conclusion, consistent with earlier phases of the same research program, was that passive exposure under typical, ventilated, real-world conditions is extremely unlikely to produce a positive result at the cutoffs federal and workplace programs actually use.
That last part is the detail employers need to hold onto. The question isn’t just “can THC show up at all after secondhand exposure.” It’s “can it show up above the cutoff a specific test is using.” Those are different questions, and cutoff levels are what separates a believable myth from an actual risk.
Why Cutoff Levels Are the Real Answer
Workplace drug tests aren’t calibrated to detect any trace amount of a substance. They’re calibrated to a specific cutoff concentration, chosen specifically to screen out incidental or trace-level exposure and flag only levels consistent with actual use. The federal government’s own oral fluid testing standards illustrate this directly. The Mandatory Guidelines for Federal Workplace Drug Testing Programs, Oral Fluid set specific initial and confirmatory cutoff concentrations for THC and other substances precisely so that incidental exposure, secondhand smoke, residual environmental contact, and similar edge cases don’t trigger a positive result on their own.
This is also why a lab-certified program matters more than people realize when a secondhand smoke claim comes up. A properly calibrated test, read against the correct cutoff, by an accredited lab, is the mechanism that already filters out the overwhelming majority of passive exposure scenarios. The cutoff isn’t an arbitrary number. It’s the line the science says separates background exposure from actual use.
What This Means for Policy and Practice
None of this means an employer should treat a secondhand smoke explanation as automatically false, or automatically true. It means the explanation should be evaluated the same way any other explanation is: through the program’s existing review process, not through a judgment call made on the spot by whoever happens to be handling the case.
A few practical points worth building into policy and training:
Don’t let the explanation bypass the normal confirmation process. Any non-negative screening result should already be going to confirmatory testing and, where applicable, a Medical Review Officer review before anyone treats it as a verified positive. That review is exactly where a claim like secondhand exposure gets a fair, consistent hearing, rather than being accepted or dismissed informally by a supervisor.
Know what your testing method and cutoff are. HR and compliance staff don’t need to be toxicologists, but they should know, in general terms, that the program’s cutoffs are set deliberately above incidental-exposure levels. That one fact answers most employee pushback without needing to relitigate the science every time.
Separate “secondhand smoke” from “legal use” arguments. These are different claims and deserve different handling. Secondhand exposure is a factual question about whether enough THC was absorbed to cross a cutoff. Legal recreational or medical use in a state where it’s permitted is a separate policy question about whether off-duty legal conduct affects employment, and it has nothing to do with how the test itself works. Conflating the two in a conversation with an employee tends to make both issues harder to resolve cleanly.
A Common Misconception Worth Addressing Directly
The most persistent misconception isn’t that secondhand exposure can never register at all. Under lab conditions designed to maximize exposure, it occasionally can, briefly, and usually below cutoff. The misconception is the leap from “detectable in a lab under extreme conditions” to “a real risk in ordinary workplace life.” A coworker smoking outside, a ride in a car with someone who smoked earlier, a brief walk past secondhand smoke at an event: none of these resemble the sealed-room, multiple-smoker, close-proximity conditions the research actually tested. Employers who understand that distance between the lab scenario and everyday exposure are better equipped to respond to the claim calmly and accurately instead of either dismissing it outright or treating it as a bigger loophole than it is.
Building This Into a Defensible Program
A testing program holds up under scrutiny when every step, collection, confirmation, review, and documentation, is consistent and well understood by the people running it. Secondhand smoke claims are a good test case for that consistency. If your team can explain, in plain terms, why cutoff levels exist and why the confirmation process is where edge-case claims get resolved, you’re already handling this correctly. If the answer currently depends on whoever happens to be in the room that day, that’s a gap worth closing with a short, written explanation your supervisors can point to.
Specimen type matters here too. Oral fluid collection, often done with a mouth swab drug test, reflects very recent exposure rather than a longer look-back window, which is part of why understanding cutoffs and confirmation steps for this specimen type specifically, rather than assuming urine testing rules apply the same way, helps a program respond to claims like this accurately.
The Bottom Line
Secondhand cannabis smoke exposure, under realistic, everyday conditions, is extremely unlikely to push oral fluid or blood THC levels above standard workplace testing cutoffs. The scenario where it can happen at all involves conditions most employees will never encounter: an unventilated space with active, nearby smoking sustained over time. For everything short of that, the cutoff levels built into the testing method are already doing the job they’re designed to do. The best response an employer can give isn’t a flat denial or an automatic pass. It’s a program that routes the claim through confirmatory testing and documented review, the same place every other explanation gets evaluated, so the result reflects the science rather than whoever’s judgment call it happens to be.
Sources
- Cone, E.J., et al. Nonsmoker Exposure to Secondhand Cannabis Smoke III: Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects, National Library of Medicine (NIH), PubMed Central.
- Substance Abuse and Mental Health Services Administration / Federal Register: Mandatory Guidelines for Federal Workplace Drug Testing Programs, Oral Fluid.
Written and reviewed by Sarah, MouthSwabDrugTests.com
